Revising the text of a mammography recall lay letter so that it is easier to comprehend can lead to better overall patient care, according to a new study published in the Journal of the American College of Radiology.

The acquisition of Aetna by CVS Health, which came at a price tag of $69 billion and brought together the nation’s third-largest health insurance provider with one of the biggest pharmacy retailers and pharmacy benefit managers (PBMs), is at risk as the transaction is still under review by a court.

Eli Lilly stocks are down 1.4% in premarket trading this week after the company announced the results of its long-awaited REWIND study, Barron’s reported.

Alzheimer’s disease, a progressive brain disorder with no known cure that affects more than 5.5 million Americans, may finally be preventable. That’s if a vaccine developed by researchers at the University of New Mexico currently being tested turns out to be viable, reports local news outlet KRQE.

The American College of Cardiology is partnering with Chicago-based company Veradigm to assemble the largest-ever ambulatory chronic disease network in the U.S., comprising more than 250,000 clinicians and 100 million patients.

Is risk-based mammography screening a more effective strategy for women 40 to 49 years old than age-based screening? A new study published in Radiology aimed to explore that very issue.  

Microsoft is launching a regional hub for AI, Internet of Things and data science in Louisville, Kentucky, according to Mayor Greg Fischer, with a focus on collaborating with partners in healthcare and manufacturing.

Aidoc announced Tuesday, June 11, that it has received FDA clearance for its AI-based solution for triaging cervical spine fractures.